Cargando…

Synchronous Oligometastatic Non-small Cell Lung Cancer Managed With Curative-Intent Chemoradiation Therapy: Long-term Outcomes From a Single Institution

PURPOSE: We examined long-term clinical outcomes among patients with synchronous oligometastatic non-small cell lung cancer (NSCLC) treated at our institution with definitive thoracic chemoradiation therapy (CRT) and local therapy to all oligometastatic lesions. METHODS AND MATERIALS: A retrospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yegya-Raman, Nikhil, Aisner, Joseph, Kim, Sinae, Sayan, Mutlay, Li, Diana, Langenfeld, John, Patel, Malini, Malhotra, Jyoti, Jabbour, Salma K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Thoracic Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639751/ https://www.ncbi.nlm.nih.gov/pubmed/31360811 http://dx.doi.org/10.1016/j.adro.2019.03.005

Ejemplares similares

Local treatment of synchronous oligometastatic non-small cell lung cancer (NSCLC)—current consensus and future perspectives
por: Almeldin, Doaa Said, et al.
Publicado: (2020)

Tumor volume reduction evaluated by cone beam computed tomography during stereotactic body radiotherapy for early stage non-small cell lung cancer
por: Gaines, Dakim K., et al.
Publicado: (2020)

Residual lymph node disease and mortality following neoadjuvant chemoradiation and curative esophagectomy for distal esophageal adenocarcinoma
por: Kandilis, Apostolos, et al.
Publicado: (2020)

Effect of cyclo-oxygenase inhibitor use during checkpoint blockade immunotherapy in patients with metastatic melanoma and non-small cell lung cancer
por: Wang, Shang-Jui, et al.
Publicado: (2020)

Dynamic Changes in Circulating Tumor DNA During Chemoradiation for Locally Advanced Lung Cancer
por: Corradetti, Michael N., et al.
Publicado: (2019)

Combining radiation therapy and immunotherapy for lung cancers: a narrative review
por: Modi, Chirag, et al.
Publicado: (2021)

Definitive Chemoradiation Associated with Improved Survival Outcomes in Patients with Synchronous Oligometastatic Esophageal Cancer
por: Matoska, Thomas, et al.
Publicado: (2023)

Prognosis and Treatment After Diagnosis of Recurrent Esophageal Carcinoma Following Esophagectomy with Curative Intent
por: Parry, K., et al.
Publicado: (2015)

Clinical outcomes and immune phenotypes associated with STK11 co-occurring mutations in non-small cell lung cancer
por: Malhotra, Jyoti, et al.
Publicado: (2022)

Eurolung risk score is associated with long-term survival after curative resection for lung cancer
por: Brunelli, Alessandro, et al.
Publicado: (2021)

Radiation Therapy for Tracheobronchial Metastases from Head and Neck Squamous Cell Carcinoma
por: Yegya-Raman, Nikhil, et al.
Publicado: (2018)

Metastasectomy or Stereotactic Body Radiation Therapy With or Without Systemic Therapy for Oligometastatic Esophagogastric Cancer
por: Kroese, Tiuri E., et al.
Publicado: (2022)

Cardiovascular Burden and Adverse Events in Patients With Esophageal Cancer Treated With Chemoradiation for Curative Intent
por: Søndergaard, Mette Marie A., et al.
Publicado: (2021)

Curative-intent radiotherapy in patients with oligometastatic lesions from colorectal cancer: A single-center study
por: He, Xiaofeng, et al.
Publicado: (2018)

Stereotactic Body Radiation Therapy in Gynecologic Oligometastases: An Effective but Underutilized Approach
por: Sherwani, Zohaib, et al.
Publicado: (2023)

Rethinking the Role of Radiation Therapy in the Treatment of Unresectable Hepatocellular Carcinoma: A Data Driven Treatment Algorithm for Optimizing Outcomes
por: Sayan, Mutlay, et al.
Publicado: (2019)

Successful treatment of a patient with oligometastatic mesothelioma to the brain
por: Li, Selena S., et al.
Publicado: (2020)

Imaging modalities in synchronous oligometastatic prostate cancer
por: Futterer, Jurgen J., et al.
Publicado: (2018)

Brachial plexopathy after stereotactic body radiation therapy for apical lung cancer: Dosimetric analysis and preliminary clinical outcomes
por: Sood, Sumit S., et al.
Publicado: (2017)

Palliative radiation and fractionation in medicare patients with incurable non-small cell lung cancer
por: Lam, Miranda B., et al.
Publicado: (2018)

Safety of combining thoracic radiation therapy with concurrent versus sequential immune checkpoint inhibition
por: von Reibnitz, Donata, et al.
Publicado: (2018)

Stereotactic MR-Guided Online Adaptive Radiation Therapy (SMART) for Ultracentral Thorax Malignancies: Results of a Phase 1 Trial
por: Henke, Lauren E., et al.
Publicado: (2018)

Long-term Clinical Outcomes and Safety Profile of SBRT for Centrally Located NSCLC
por: Arnett, Andrea L.H., et al.
Publicado: (2019)

Increases in Serial Pretreatment (18)F-FDG PET-CT Metrics Predict Survival in Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiation Therapy
por: Prionas, Nicolas D., et al.
Publicado: (2018)

Interobserver reliability in describing radiographic lung changes after stereotactic body radiation therapy
por: Kalman, Noah S., et al.
Publicado: (2018)

Scanning Beam Proton Therapy versus Photon IMRT for Stage III Lung Cancer: Comparison of Dosimetry, Toxicity, and Outcomes
por: Zou, Zhenwei, et al.
Publicado: (2020)

Outpatient Anesthesia Facilitates Stereotactic Body Radiation Therapy for Early Stage Lung Cancer Patients With Advanced Cognitive Impairments
por: Gandhidasan, Senthilkumar, et al.
Publicado: (2019)

Early Outcomes of Patients With Locally Advanced Non-small Cell Lung Cancer Treated With Intensity-Modulated Proton Therapy Versus Intensity-Modulated Radiation Therapy: The Mayo Clinic Experience
por: Yu, Nathan Y., et al.
Publicado: (2019)

Fatal Radiation Pneumonitis: Literature Review and Case Series
por: Keffer, Stephen, et al.
Publicado: (2019)

Survival After Induction Chemotherapy and Chemoradiation Versus Chemoradiation and Adjuvant Chemotherapy for Locally Advanced Rectal Cancer
por: Kim, Jin K, et al.
Publicado: (2022)

Long-Term Postsurgical Outcomes of Neoadjuvant Chemoradiation (CROSS) Versus Chemotherapy (FLOT) for Multimodal Treatment of Adenocarcinoma of the Esophagus and the Esophagogastric Junction
por: Gebauer, Florian, et al.
Publicado: (2023)

Longer Time Interval from Neoadjuvant Chemoradiation to Surgery is Associated with Poor Survival for Patients Without Clinical Complete Response in Oesophageal Cancer
por: Xiao, Xin, et al.
Publicado: (2022)

Defining Oligometastatic Bladder Cancer: A Systematic Review
por: Bamias, Aristotelis, et al.
Publicado: (2023)

Cost‐effectiveness of chemoradiation followed by esophagectomy versus chemoradiation alone in squamous cell carcinoma of the esophagus
por: Salcedo, Jonathan, et al.
Publicado: (2019)

Synchronous Triple Primary Lung Cancers: A Case Report
por: Yoon, Hyun Jung, et al.
Publicado: (2014)

Oligometastatic Prostate Cancer
por: Stevens, Daniel J., et al.
Publicado: (2016)

Outcomes by time to definitive chemoradiation treatment for patients with muscle-invasive bladder cancer
por: Kotha, Nikhil V., et al.
Publicado: (2022)

Results of surgical treatment of primary lung cancer with synchronous brain metastases
por: Bella, Mariusz Jan, et al.
Publicado: (2015)

Local and metastatic curative radiotherapy in patients with de novo oligometastatic prostate cancer
por: Reverberi, C., et al.
Publicado: (2020)

Stereotactic radiotherapy of oligometastatic disease: a new paradigm for a curative approach
por: Krengli, Marco, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hher7vcjuosk2l3kcblm1or0n7